FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

UK Drug Regulator Reports Fewer Ad Complaints

[ Price : $8.95]

The UKs health products regulator says its increased review of new drug launches and ads has led to fewer complaints and fewer cor...

Asthma Drugs Safety Review Calls for Stronger Warning

[ Price : $8.95]

FDA plans to study the safety of asthma drugs used in children after an advisory panel recommends a stronger warning on long-actin...

Roche to Stop Making Roferon-A

[ Price : $8.95]

Roche tells FDA that is discontinuing production and marketing of Roferon-A (Interferon alfa-2a, recombinant) due to product lifec...

TMJ Implants Alleges 94 Errors in GAO Report

[ Price : $8.95]

Embattled device maker TMJ Implants says it found 94 false, misleading or erroneous statements in a GAO report in September about ...

Panel to Discuss Adolors Entereg

[ Price : $8.95]

Federal Register Notice: FDAs Gastrointestinal Drugs Advisory Committee will meet 1/23/08 to discuss Adolor Corp.s Entereg for acc...

FDA, EU Adopt Orphan Drug Application

[ Price : $8.95]

FDA and the European Union adopt a common application form sponsors can use to apply for orphan drug designation.

Company Sponsorship Biases Med Ed: Journal

[ Price : $8.95]

The British journal Nature says drug company funding is biasing continuing medical education programs.

FDA OKs Barrs Generic Combunox

[ Price : $8.95]

FDA approves a Barr Pharmaceuticals ANDA for a generic version of Forest Pharmaceuticals Combunox pain relief tablets.

Advocate Backs Learned Intermediary End

[ Price : $8.95]

Government Accountability Project executive director Mark Cohen says more states should drop the learned intermediary doctrine and...

FDA Panel Backs Stronger Warning on Flu Drugs

[ Price : $8.95]

An FDA pediatric advisory committee votes to add stronger precautionary labeling to flu drugs Tamiflu (Roche) and Relenza (GlaxoSm...